Debra BorchardtAugust 4, 2023
The company has high expectations for its MM-120 LSD drug.
Tag: LSD
Debra BorchardtAugust 4, 2023
Adam JacksonJune 27, 2023
Public comment on the draft proposal will be collected for the next 60 days.
Debra BorchardtJune 12, 2023
Hallucinogenic trips may limit widespread use of psychedelic therapy.
Debra BorchardtMay 25, 2023The battle over the board of psychedelic company Mind Medicine (NASDAQ: MNMD) continues with the latest volley being shot by the current company roster. MineMed published a report by Greenleaf Health, Inc. assessing the company’s MM-120 (lysergide D-tartrate) development strategy. The report’s main focus is to refute the claims by the group FCM MM Holdings that […]
StaffApril 18, 2023
Celebrations will be happening in New York, San Francisco.
Dave HodesNovember 30, 2022Researchers looking more closely at similarities of compounds and responses.
Dave HodesNovember 11, 2022
Carvin Medicines and Alpex Pharma partner to conduct medical trials and research.
Dave HodesNovember 10, 2022LSD is back with a flurry of new applications to treat a broad array of conditions.
Dave HodesSeptember 15, 2022
The psychedelics industry is attracting more attention from less scrupulous operators who see the reward as worth the risk.
Adam JacksonAugust 24, 2022Research provides new evidence of LSD's therapeutic ability to treat mental health issues.
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.